IGC Pharma, Inc. Share Price
Stocks
IGC
US45408X3089
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
NYSE
01:30:00 03/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 0.2749 USD | +1.81% |
|
-2.66% | -2.31% |
| Market Cap | 2.84Cr 2.53Cr 2.36Cr 2.15Cr 4.05Cr 273.21Cr 4.09Cr 29Cr 11Cr 139.67Cr 11Cr 10Cr 448.25Cr | P/E 2026 * |
-2.75x | P/E 2027 * | -3.44x |
|---|---|---|---|---|---|
| Enterprise Value | 2.84Cr 2.53Cr 2.36Cr 2.15Cr 4.05Cr 273.21Cr 4.09Cr 29Cr 11Cr 139.67Cr 11Cr 10Cr 448.25Cr | EV / Sales 2026 * |
29.7x | EV / Sales 2027 * | 29.7x |
| Free-Float |
86.49% | Yield 2026 * |
-
| Yield 2027 * | - |
NYSEUSD
| Markets | Quality | ||
|---|---|---|---|
NYSE
| IGC | Delayed | |
CBOE
| IGC | Real-time | |
|
Deutsche Boerse AG
| IGS1 | Delayed | |
|
Börse Stuttgart
| IGS1 | Delayed | |
|
Tradegate
| IGS1 | Real-time | |
|
Boerse Muenchen
| IGS1 | Real-time |
| 1 day | +1.81% | ||
| 1 week | -2.66% | ||
| Current month | +2.23% | ||
| 1 month | -7.91% | ||
| 3 months | -2.14% | ||
| 6 months | +3.70% | ||
| Current year | -2.31% |
| 1 week | 0.27 |  | 0.3 |
| 1 month | 0.26 | | 0.3 |
| Current year | 0.24 | | 0.36 |
| 1 year | 0.24 | | 0.45 |
| 3 years | 0.24 | | 0.91 |
| 5 years | 0.24 | | 1.79 |
| 10 years | 0.19 | | 14.58 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ram Mukunda
CEO | Chief Executive Officer | 67 | 29/04/2005 |
Claudia Grimaldi
DFI | Director of Finance/CFO | 55 | 09/05/2018 |
Benysh Qureshi
COO | Chief Operating Officer | - | 01/08/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Ram Mukunda
CHM | Chairman | 67 | 29/04/2005 |
Claudia Grimaldi
BRD | Director/Board Member | 55 | 23/03/2022 |
Richard Prins
CHM | Chairman | 69 | 01/01/2012 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 25/09/26 | Don | Founder | -2,00,000 | 0.1935% | ||
| 25/09/26 | Don | Chief Financial Officer | -1,50,000 | 0.1451% | ||
| 30/06/26 | Free | Founder | 22,26,475 | 2.2244% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.81% | -2.66% | -32.24% | -21.19% | 2.84Cr | |
| +4.16% | +3.04% | +49.37% | +94.17% | 7.42TCr | |
| -3.11% | -3.53% | +20.19% | +81.44% | 5.74TCr | |
| +0.89% | -0.63% | +2.17% | +36.19% | 4.76TCr | |
| +0.36% | +0.81% | +342.39% | +742.40% | 4.43TCr | |
| -0.96% | -4.50% | +24.96% | +35.38% | 4.25TCr | |
| -0.20% | -0.77% | +4.13% | +105.50% | 4.07TCr | |
| -0.54% | +2.93% | +9.31% | +50.41% | 3.1TCr | |
| -2.68% | +2.92% | +29.33% | +22.72% | 2.85TCr | |
| +0.05% | -1.64% | -8.14% | -11.37% | 2.43TCr | |
| Average | -0.02% | -0.79% | +44.15% | +113.57% | 3.91TCr | |
| Weighted average by Cap. | +0.12% | -0.84% | +56.95% | +138.25% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 10L 9L 8L 7L 13.66L 9.21Cr 13.78L 96.14L 37.25L 4.71Cr 35.97L 35.19L 15Cr | 10L 9L 8L 7L 13.66L 9.21Cr 13.78L 96.14L 37.25L 4.71Cr 35.97L 35.19L 15Cr |
| Net income | -1Cr -89.06L -83.13L -75.77L -1.43Cr -96Cr -1.44Cr -10Cr -3.9Cr -49Cr -3.76Cr -3.68Cr -158.1Cr | -85.08L -75.59L -70.55L -64.31L -1.21Cr -82Cr -1.22Cr -8.54Cr -3.31Cr -42Cr -3.19Cr -3.12Cr -134.19Cr |
| Net Debt | - | - |
Employees
70
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/26/02 | $0.2749 | +1.81% | 6,33,240 |
| 01/26/01 | $0.2700 | +0.41% | 4,59,170 |
| 30/26/30 | $0.2689 | +0.52% | 8,12,169 |
| 29/26/29 | $0.2675 | -2.37% | 5,25,001 |
| 28/26/28 | $0.2740 | -2.97% | 11,03,963 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.2749USD
Average target price
6.000USD
Spread / Average Target
+2,082.61%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IGC Stock
Select your edition
All financial news and data tailored to specific country editions
